Vijaya Diagnostic Centre Reviews

Vijaya Diagnostic Centre Limited is a leading integrated diagnostic service provider in India, established in 1981 by Dr. Sura Surendranath Reddy. Headquartered in Hyderabad, Telangana, the company has grown from a single centre into one of India's largest B2C-focused diagnostic chains. It is publicly listed on both the National Stock Exchange (NSE: VIJAYA) and the Bombay Stock Exchange (BSE: 543350). The organization is currently led by Ms. Sura Suprita Reddy, who serves as the Managing Director and CEO, and Dr. Sura Surendranath Reddy as the Executive Chairman. The company operates a comprehensive business model that offers a "one-stop solution" for diagnostic needs, providing over 2,000 pathology tests and 700 radiology tests under one roof. Its services span a wide spectrum, including clinical pathology, molecular diagnostics, biochemistry, and advanced radiology such as 3T MRI, PET-CT, and SPECT scans. Vijaya Diagnostic is notably recognized as a pioneer in South India for introducing advanced technologies like PET-CT and 3D mammography. As of late 2025, its network has expanded to 162 diagnostic centres and 17 NABL-accredited laboratories across 27 cities in states including Telangana, Andhra Pradesh, Maharashtra, West Bengal, and Karnataka. A key differentiator for the company is its B2C-centric approach, which contributes approximately 92% of its revenue. This model is supported by a hub-and-spoke infrastructure that ensures high-quality service delivery across urban and semi-urban locations. The company also engages with over 450 corporate clients for preventive wellness programs. For the fiscal year ending March 31, 2025, Vijaya Diagnostic reported a revenue of INR 700 crore, reflecting a compounded annual growth rate of 23%. In Q4 FY2026, the company continued its upward trajectory, reporting revenue of INR 219 crore with a net profit of INR 47.9 crore. Strategically, the company has pursued growth through both organic expansion and inorganic acquisitions, such as the 2023 acquisition of PH Diagnostics in Pune and the merger of Medinova Diagnostic Services in 2024. These moves have strengthened its footprint in Western and Eastern India. Looking ahead to FY2027, management plans to add several new hubs and spokes while launching advanced genomic testing. With a dedicated team of over 3,000 professionals, including more than 300 specialized radiologists and pathologists, Vijaya Diagnostic Centre remains committed to clinical excellence, patient safety, and its mission of providing accurate, timely, and accessible diagnostic care to millions of patients across India.

Employee review

Learned a ton here. Fast-paced but the people make it worth it.

Employee review

Solid work-life balance and managers who actually listen. Would recommend.